X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (3) 3
aged (3) 3
female (3) 3
humans (3) 3
male (3) 3
middle aged (3) 3
neoplasm staging (3) 3
oncology (3) 3
prognosis (3) 3
radiotherapy (3) 3
survival rate (3) 3
aged, 80 and over (2) 2
article (2) 2
care and treatment (2) 2
chemoradiation (2) 2
chemotherapy (2) 2
clinical-trials (2) 2
combined modality therapy (2) 2
follow-up studies (2) 2
index medicus (2) 2
radiation-therapy (2) 2
adenocarcinoma - mortality (1) 1
adenocarcinoma - secondary (1) 1
adenocarcinoma - therapy (1) 1
adolescent (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
brain metastases (1) 1
brain neoplasms - radiotherapy (1) 1
cancer (1) 1
cancer therapies (1) 1
carboplatin - administration & dosage (1) 1
carcinoma (1) 1
carcinoma, large cell - mortality (1) 1
carcinoma, large cell - secondary (1) 1
carcinoma, large cell - therapy (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
carcinoma, non-small-cell lung - secondary (1) 1
carcinoma, non-small-cell lung - therapy (1) 1
carcinoma, squamous cell - mortality (1) 1
carcinoma, squamous cell - secondary (1) 1
carcinoma, squamous cell - therapy (1) 1
cetuximab (1) 1
chemoradiotherapy (1) 1
child (1) 1
clinical investigations (1) 1
clinical neurology (1) 1
cognition (1) 1
cognition disorders - drug therapy (1) 1
cognition disorders - etiology (1) 1
competing risk (1) 1
cranial irradiation - adverse effects (1) 1
disease progression (1) 1
dosage and administration (1) 1
double-blind method (1) 1
epstein-barr-virus (1) 1
evaluation (1) 1
excitatory amino acid antagonists - therapeutic use (1) 1
external-beam irradiation (1) 1
hematology, oncology and palliative medicine (1) 1
histology (1) 1
immunophenotypic analysis (1) 1
induction (1) 1
k dm oncology (1) 1
lethal midline granuloma (1) 1
lung cancer (1) 1
lung cancer, non-small cell (1) 1
lung neoplasms - mortality (1) 1
lung neoplasms - pathology (1) 1
lung neoplasms - therapy (1) 1
lymphoma (1) 1
lymphoma - pathology (1) 1
lymphoma - radiotherapy (1) 1
lymphoma - therapy (1) 1
lymphomas (1) 1
malignant-lymphomas (1) 1
memantine (1) 1
memantine - therapeutic use (1) 1
moderate vascular dementia (1) 1
multivariate analysis (1) 1
nasal cavity (1) 1
neoplasm metastasis (1) 1
neurocognitive function (1) 1
neuroprotective agents (1) 1
neuropsychological tests (1) 1
non-hodgkins-lymphomas (1) 1
non-small cell lung cancer (1) 1
nose cancer (1) 1
nose neoplasms - pathology (1) 1
nose neoplasms - radiotherapy (1) 1
nose neoplasms - therapy (1) 1
paclitaxel - administration & dosage (1) 1
paranasal sinus neoplasms - pathology (1) 1
paranasal sinus neoplasms - radiotherapy (1) 1
paranasal sinus neoplasms - therapy (1) 1
paranasal sinuses (1) 1
patient-reported outcomes (1) 1
phase-ii (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.